

Precision Bio-Interface
Plasma-Enhanced Biomaterials for Oncology
Validated Performance
Quantitative Scientific Metrics
100%
Filling of the resected tumor site for a Personalized medicine
~90%
Healthy cells viability to ensure selectivity
6-fold
Reduction of the chemotherapy dosis
From ~75 to 25%
Relapses demonstrated in in vivo studies
Explore our body of peer-reviewed scientific articles in the fields of plasma medicine, biomaterials and oncology and cold plasma, validating PlasmOnCo's plasma-engineered technology.
Peer-Reviewed Manuscripts
Key publications from the PlasmaMED Lab Research Group at UPC towards cold atmospheric plasma interaction with hydrogel-based biomaterials, localized RONS release dynamics, biological response and microenvironment modulation.
• M. Živanić, A. Espona-Noguera, A. Privat Maldonado, P. Matušů, F. Tampieri, M.P. Ginebra, A. Lin, E. Smits, A. Bogaerts, C. Canal. Plasma-Treated Hydrogel for Combined RONS and Chemotherapy Delivery: A Proof-of-Concept In Ovo. Adv. Funct. Mater., e02779 (2025)
• J. Tornin, C. Labay, F. Tampieri, M.P. Ginebra, C. Canal. Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures, Nature Protocols, 16, 2826 (2021)
• C. Labay, M. Roldán, F. Tampieri, A. Stancampiano, P. Escot Bocanegra, M.-P. Ginebra, C. Canal, Enhanced Generation of Reactive Species by Cold Plasma in Gelatin Solutions for Selective Cancer Cell Death, ACS Appl. Mater. Interfaces, 12, 42, 47256 (2020)
• M. Živanić, A. Espona-Noguera, H. Verswyvel, E. Smits, A. Bogaerts, A. Lin, C. Canal. Injectable Plasma-Treated Alginate Hydrogel for Oxidative Stress Delivery to Induce Immunogenic Cell Death in Osteosarcoma, Adv. Funct. Mater., 34, 2312005 (2024)
• C. Labay, I. Hamouda, F. Tampieri, M.P. Ginebra, C. Canal. Production of reactive species in alginate hydrogels for cold atmospheric plasma-based therapies. Scientific Reports, 9, 16160 (2019)
Advance Oncology Research
Collaborate with our team to explore the potential of plasma-engineered biomaterials in your next breakthrough.
Plasma Treatment
Molecular Bio-Functionalization
Targeted Localized Implantation
Local Drug Release
Cold atmospheric plasma functionalization precisely implants reactive oxygen and nitrogen species (RONS) into hydrogel polymer networks.
Our process integrates specific biomolecules, programming the scaffold for targeted cellular interaction and therapeutic response.
Engineered scaffolds are designed for high-precision localized delivery, minimizing systemic exposure and maximizing therapeutic efficacy.
Customizable degradation rates ensure sustained and controlled release kinetics, perfectly matched to tumor histology and treatment protocols.
